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ABSTRACT
Background: Retinopathy of prematurity is a leading but preventable cause of blindness in
children worldwide. In the United States, approximately 600 premature neonates become
legally blind each year. Over 50,000 children suffer visual impairment as a result of ROP
globally. Laser photocoagulation therapy is a procedure to treat ROP and improve short and
long-term outcomes.1 Pain management during this procedure is imperative to prevent adverse
events in the neonate. An optimal analgesic agent that is safe and efficacious is needed to
provide adequate analgesia.2 The purpose of this review was to identify effective treatment
methods to reduce pain in neonates undergoing procedures for ROP.1
Methods: An extensive search was performed using online electronic journal databases
including CINAHL Plus with Full Text, PubMed, and Embase to identify research studies
within the past 7 years that evaluated the effectiveness of intravenous fentanyl for pain
management in infants undergoing ROP procedures.
Results: Of the articles reviewed, 5 were considered relevant for review. Research studies that
evaluated the effectiveness of analgesia in the neonatal population during screening and laser
photocoagulation for ROP were identified.

Keywords: Retinopathy of prematurity, analgesia, fentanyl, sucrose, laser photocoagulation,
laser surgery
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INTRODUCTION
Problem Identification
Retinopathy of prematurity (ROP) is a vasoproliferative disease that primarily affects the
developing retinal vessels of premature neonates.1 This immature retinal vasculature disorder
was recognized in 1942 and initially named retrolental fibroplasia.2 The pathogenesis of ROP is
not well understood, but endothelial growth factor (VEGF) has been noted to play a crucial role
in its development.3 The retina does not have blood vessels until approximately 16 weeks
gestation. Vessels then begin to branch out from the optic disc and reach the periphery of the eye
one month after birth.2 Abnormalities in vasculogenesis and neovascularization are caused by
dysregulation of VEGF.3
Within the first few weeks of life, approximately 30% of premature infants weighing less
than 1500g develop ROP. Premature infants exposed to high oxygen concentrations in confined
spaces such as incubators are at higher risk for developing ROP. Methods to prevent ROP were
aimed at limiting concentrations of oxygen administered to preterm infants to 40%. However,
morbidity and mortality resulted when concentrations of oxygen were restricted.2 Although
retinal detachment and blindness may result from severe disease,1 laser therapy (LT) can help
prevent blindness by suppressing overproduction of VEGF in the retina. It also ablates peripheral
retina ischemic areas by inducing the regression of new vessels.3 Laser therapy reduces the risk
of poor visual outcomes1 but is well known to be a painful procedure. It involves a significant
amount of pain for the neonate. Yet, evidence is lacking with regard to an analgesia protocol
during laser surgery for ROP.4
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Background
Approximately 28,300 to 45,600 infants suffer from irreversible visual impairment due to
ROP annually worldwide. Those at the highest risk of developing ROP are infants weighing
1250g or less before 31 weeks gestation at delivery.3 The risk of developing ROP is significantly
higher in sicker infants with low birth weights. Risk is also increased in those requiring
continuous positive airway pressure (CPAP), low Apgar scores at 5 minutes, use of surfactant or
erythropoietin, meningitis, sepsis, patent ductus arteriosus, abdominal distension, intraventricular
hemorrhage, need for blood transfusions, or diet intolerance.2
There is no definitive current anesthetic practice, but general anesthesia or sedation can
be used for laser surgery for ROP. In hospitals in the United Kingdom, the NICU intubates and
sedates these neonates. This is performed in approximately 90% of cases. The rationale is to
prevent the adverse respiratory events that can occur during or after laser treatment. To improve
analgesia techniques necessary to manage pain in the neonate undergoing laser photocoagulation
for ROP, a further evaluation of the well-defined pain responses in neonates and appropriate
anesthetics is needed.5
Scope of the Problem
Survival rates continue to improve for premature infants. This has led to an exponential
rise in the diagnosis of retinopathy of prematurity, which has been observed in the developing
world since the 1980s. However, increased immaturity in these infants that results from the
advances in neonatal intensive care has led to an increased incidence of ROP. If left untreated,
ROP may lead to the development of strabismus, retinal detachment, vitreous hemorrhage,
myopia, vitreoretinal fibrosis, secondary angle-closure glaucoma, and is a significant cause of
vision loss in premature neonates.2
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Retinopathy of prematurity is a leading but preventable cause of childhood blindness
worldwide.3 Screening and diagnosis determine treatment options. Laser treatment is the
recommended primary treatment for type 1 ROP.5 Laser photocoagulation is the most effective
therapy in limiting its progression but can be painful. The primary source of pain is thought to be
the eyelid speculum, but pharmacological analgesic measures are often limited in preterm infants
due to the vulnerability of this population.2 There are limited studies of low-dose opioid therapy
for analgesia in neonates undergoing laser photocoagulation for ROP. This is likely the cause of
the knowledge deficit of an efficacious analgesia protocol.
Consequences of the Problem
Pain contributes to instability in neonates.5 Increased hemodynamic instability, apnea,
and raised intracranial pressures may result from untreated pain in preterm neonates.
Additionally, altered pain processing, impaired visual perceptual ability, and attention deficit
disorder are some long-term consequences associated with pain. Thus, pain management in
preterm neonates is of great importance.4
Several risks must be evaluated when considering laser therapy for premature infants, as
many are likely to have chronic lung disease that leads to respiratory instability and other
systemic consequences of their prematurity. General anesthesia and intravenous sedation can
lead to respiratory depression in neonates that necessitate endotracheal intubation and
ventilation. Reintubation carries its own risks and can lead to acute trauma to the mouth, larynx,
pharynx, and nose while contributing to bradycardia and hypoxia.5 Without establishing a
protocol to effectively manage pain in neonates during laser surgery, they remain at risk for
adverse effects such as bradycardia, apnea, oliguria and feeding intolerance.
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Knowledge Gaps
Oral sucrose is the most commonly used analgesic to reduce pain behaviors in neonates
in the neonatal intensive care unit (NICU).4 While oral glucose may provide comfort during
painful procedures, pain control remains problematic.2 Currently, differences exist in anesthetic
care practices for ROP. There is a need to develop an anesthesia care plan for laser therapy for
ROP. Anesthetic practices may vary due to the safety concerns and differing expertise of
individual anesthetists, ophthalmologists, and neonatologists.5
In a survey of American ophthalmologists and neonatologists, 60% preferred intravenous
sedation to general anesthesia. A significant failure rate was observed in IV sedation by
neonatologists attempting to provide analgesia without the constraints of an anesthetist and an
operating theater.1 Anesthetic preference and procedure frequency may impact the choice of
anaesthetic.5 While general anesthesia with intubation may be superior to IV sedation because it
facilitates ideal operating conditions, it predisposes these vulnerable patients to adverse reactions
and the risks associated with intubation and ventilation.1 The analgesia/sedation protocol used
for laser therapy for ROP in a multicenter observational study in Japan, demonstrated a decrease
in pain response when fentanyl was used. While research continues to identify prevention and
alternative treatments for ROP, more research and evidence are needed to improve analgesia
during laser therapy for ROP.4
Proposal Solution
There are multiple approaches to the anesthetic management of preterm infants
undergoing laser therapy.1 General anesthesia or sedation with analgesia is commonly used.4
However, the most effective anesthesia regimen with the lowest risk of perioperative adverse
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events remains to be identified. While anesthetists and neonatologists can provide anesthesia and
sedation, there is no consensus on an accepted protocol describing appropriate analgesic agents.1
Opioid therapy can be used efficaciously for analgesia in neonates undergoing laser
photocoagulation for ROP without increasing the risk of respiratory depression and apnea, which
can subsequently lead to intubation and mechanical ventilation. An optimal analgesic agent that
is a safe and effective option for managing pain in this population is needed.4 An effective
alternative approach using opioid sedation is necessary to avoid volatile anesthetics and repeated
anesthetic exposure which may affect neurodevelopment.1
Anesthesia providers are responsible for minimizing pain associated with procedures and
surgical interventions. The efficacy of a fentanyl infusion in comparison to oral sucrose to
provide optimal pain management during laser surgery for ROP should be evaluated to ensure
optimal care.4 This goal can be accomplished by evaluating the literature for analgesic
techniques that provide effective pain management to facilitate laser surgery for ROP, which can
be disseminated to improve clinical knowledge.
Summary of the Literature
Anesthetic support varies greatly, and there are no specific guidelines for which type of
anesthesia is preferable.6 This is likely due to the limited literature that is available for anesthetic
management for ROP screening and therapy.7 The open label randomized trial by Sethi et al.4
compared oral sucrose and a low dose fentanyl infusion. It is the first randomized controlled
study with an adequate sample size to assess the effect of sucrose and fentanyl in the first 24
hours post procedure. It minimized bias by using independent clinicians to assess primary and
secondary outcomes. Oral sucrose was not effective in pain reduction as evidenced by the
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percentage of time the infants spent crying. Intravenous fentanyl was associated with a decreased
pain response and observed to be a safe analgesic post procedure.4
To ensure that infants receive optimal intervention, safe and effective anesthesia
manipulation is necessary for ROP procedures. Fentanyl sedation and general anesthesia were
well tolerated without life-threatening events. Yet, the use of general anesthesia can lead to
back-and-forth transfer of an infant to a higher level hospital.6 Opioid analgesia avoids the risks
associated with general anesthesia such as complications with postoperative extubation.8
However, opioid dosing must be optimized to prevent potential oversedation, accompanying
postoperative pain, and prolonged ventilation.6
While ketamine is a potent analgesic that does not require intubation, thereby preserving
airway patency and respiratory function, its use is questionable due to significant movement and
concerns regarding neurotoxicity.9 Intravenous fentanyl is more potent, has a rapid onset of
action, and penetrates the central nervous system.8 Surgery was successful with fentanyl,
intubation was avoided, and no serious adverse events were encountered.10
Methods
Eligibility Criteria
Studies for this literature review were evaluated and chosen according to the constructed
PICO question and objectives of the project. Inclusion criteria limited the search to studies
published in the past 7 years, written in or translated to English, and with full-text availability.
Exclusion criteria restricted the search to studies that contained the intravenous analgesic agent
fentanyl. The studies were focused on procedures used in the screening and treatment of ROP.
All database sources used for the research project were accessed via the online library for Florida
International University (FIU). Based on the clinical question developed, keywords searched in

11
the appropriate Boolean operators include retinopathy of prematurity, analgesia, fentanyl,
sucrose, laser photocoagulation, and laser surgery.
Search Strategy
Online databases searched include The Cumulative Index to Nursing and Allied Health
Literature (CINAHL) Plus with Full Text, PubMed, and Embase. The Preferred Reporting Items
for Systematic Reviews and Meta-Analyses (PRISMA) further guided the literature review.
Assisted by the medical and health science librarians, keywords searched include: (retinopathy of
prematurity OR ROP) AND (analgesia OR fentanyl) AND (laser surgery OR laser therapy OR
laser photocoagulation) AND (sucrose). The initial search, using the inclusion and exclusion
criteria, generated 482 articles. CINAHL yielded 264 articles, PubMed yielded 206 articles, and
Embase yielded 58 articles. Randomized trials, retrospective studies, and observational studies
were selected for inclusion. Duplicates articles were removed. The abstracts of 19 articles were
reviewed. Of these, 5 met the criteria and were selected for a full text review.
Table 1. Database Search
Table Database
CINAHL

Key concepts/words

PubMed

“Retinopathy of prematurity OR ROP”
AND “analgesia OR fentanyl OR sucrose” AND
“laser surgery OR laser therapy OR laser
photocoagulation”



“Retinopathy of prematurity OR ROP”
AND “analgesia OR fentanyl OR sucrose” AND
“laser surgery OR laser therapy OR laser
photocoagulation”



Embase

“Retinopathy of prematurity OR ROP”
AND “analgesia OR fentanyl OR sucrose” AND
“laser surgery OR laser therapy OR laser
photocoagulation”

Filters applied
 Publication date 20152022
 Full text
 English







Publication date 20152022
Full text
English
Publication date 20152022
Full text
English
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Study Selection
By utilizing Dearholt and Dang’s recommendations and practice tools for appraising
research evidence, 5 studies were identified for inclusion.11 Two well-designed randomized
trials, an observational study, and 2 retrospective studies were selected as they identified key
concepts of the of the PICO question. All of the studies used intravenous fentanyl as an analgesic
agent for pain management during ROP procedures. The authors emphasized the efficacy of
intravenous fentanyl in reducing pain and maintaining a good level of analgesia in infants who
undergo ROP therapy.10 Articles by Sethi et al. and Madathil et al. are randomized trials.
Retrospective studies were conducted by Piersigilli et al. and Jiang et al. Only one observational
study by Örge et al. was used.
Table 2. Inclusion and Exclusion Criteria
Inclusion
Population:
 Infants diagnosed with ROP

Exclusion
Population:
 Infants with cardiac anomalies

Intervention
 Intravenous therapy
 Fentanyl
 Ketamine
 Topical anesthetic
 Sucrose

Intervention:
 Intranasal fentanyl
 Midazolam

Outcomes:
 Decrease in pain scale scores
Type of study:
 Randomized trials
 Retrospective studies
 Observational studies

Outcomes:
 Articles with results that do not
contain numerical data
Type of study:
 Studies using human subjects
 Studies without full texts
 Books
 Magazines
 Dissertations
 Editorials
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Results
As previously noted, of the articles reviewed, five were considered relevant for review.
Research studies that evaluated the effectiveness of analgesia in the neonatal population during
screening and laser photocoagulation for ROP were identified. The quality and validity of each
study was thoroughly evaluated. A critique of each study is provided.11
Review
The study by Sethi et al. was an open-label parallel randomized clinical trial that ranks as
Level 1 evidence. The focus of the study was explicitly stated in the title: fentanyl versus 24%
oral sucrose for ROP in premature infants. The abstract neither describes each section nor
includes the time frame for the study. No statistical information is presented in the introduction.
The article's purpose is stated in the introduction and discusses the potential benefits of an
analgesic agent that is safe and efficacious in premature infants.
The randomized trial was based on recent research and supported the need for the study.
The materials and methods used include all spontaneously breathing preterm neonates. Specific
exclusion criteria were met prior to enrollment. No prophylactic respiratory support was
provided during the procedure. Topical anesthesia, one drop of 0.5% paracaine, was
administered every 20 minutes during the procedure. An assistant was present to immobilize the
neonate's head in a sniffing position to ensure airway patency. An intravenous catheter was
placed before the laser therapy. The fentanyl group received a dose of 1mcg/kg/hr via infusion
15 min prior to the procedure and continued until the procedure ended. The control group
received a single 2ml oral dose of 24% sucrose from the same trained staff prior to the procedure
without any repetitive dosing.
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Randomization was performed using computer-generated numbers to allocate the neonates
into groups. The use of a computer-generated program ensures reliability and validity when
randomizing neonates that meet the inclusion criteria. The nature of the intervention precluded
blinding in the study, but outcome assessors were blinded to the group assignment to minimize
bias. The sample size is sufficient, with 29 infants in the fentanyl group and 28 in the oral 24%
sucrose group. Except for delivery mode, baseline demographic variables were comparable
between the two groups. The primary outcome evaluated was the proportion of time spent crying
during the procedure. Secondary outcomes included premature infant pain profile-revised (PIPPR) scores, apnea, need for mechanical ventilation, salivary cortisol levels, urinary incontinence,
and/or feeding intolerance in the first 24 hours post-procedure. PIPP-R score grades
physiological indicators (heart rate and oxygenation), behavioral indicators (eye squeeze, brow
bulge, and nasolabial furrow), gestational age (GA), and adjusts for gestational age. Voice and
video recording were performed with a baseline behavioral state established with a video
recording before the start of the procedure.
The average PIPP-R score at any time and the median proportion of time spent crying
during the procedure were significantly less in the fentanyl group compared to the oral 24%
sucrose group. The proportion of infants experiencing apnea during and within 24 hours after the
procedure was the same between the groups. None of these infants required ambu-bagging as
tactile stimulation was a sufficient intervention. Thus, low-dose fentanyl infusion was found to
be safe in the first 24 hours post-procedure.
The inability to blind the intervention groups is the major limitation of the study.
Additionally, salivary cortisol levels, a marker for stress, could only be obtained in 53% of the
study population due to difficulty in extracting saliva. A low-dose fentanyl infusion is effective
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and safe for treating pain during laser treatment for ROP. However, more studies are needed to
optimize the dose of fentanyl to provide better analgesia.
The retrospective study by Piersigilli et al. evaluated the clinical charts of 13 neonates.
These neonates were sedated with propofol and given an analgesic agent, fentanyl, for laser
treatment of ROP. The title accurately describes what is being investigated but does not mention
the population that is studied. A concise overview of each section of the study is provided in the
abstract. The introduction provides statistical information on the scope of the problem. It clearly
states that the study aims to evaluate the effectiveness of propofol sedation in conjunction with
fentanyl analgesia to avoid intubation and mechanical ventilation during and after laser
photocoagulation treatment for ROP in preterm infants.
Retrospective analysis of clinical data was performed to evaluate the effectiveness of the
propofol and fentanyl protocol to avoid intubation and mechanical ventilation. Unlike the
previous randomized trial, baseline ventilation status and rate of complications were used to
assess the protocol's efficacy. These complications include apneic events, temperature instability,
desaturations, bradycardic episodes, and changes in ventilation status. The standardized sedation
flow sheet containing vital signs (temperature, heart rate, blood pressure, and oxygen saturation)
in 3-minute intervals in the medical record was utilized for this purpose.
Compared to the randomized trial by Sethi et al., a laryngeal mask airway (LMA) was
placed, and a flow-inflating resuscitation bag was used instead of maintaining spontaneous
breaths. No topical analgesia was provided. Propofol is a short-acting hypnotic agent that lacks
an analgesic effect. Therefore, a dose of 2 mg/kg of 5% propofol was administered via a
peripheral line inserted prior to the procedure until sedation was achieved to a maximum dose of
4mg/kg followed by a bolus of 1 ug/kg of fentanyl. A continuous propofol infusion was initiated
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at 4mg/kg/hr and increased to 6 mg/kg/hr to maintain adequate sedation. The LMA was
removed, the propofol infusion was discontinued, and a blood gas analysis was performed at the
end of the surgery.
No bradycardia or hypotension was observed. An increase in heart rate and a slight
decrease in blood pressure were noted but remained within normal parameters for the age. Two
infants presented with some episodes of oxygen desaturation and apnea, which resolved after
using the oxygen and flow-inflating resuscitation bag. Two neonates required NCPAP for 2
hours to relieve apnea spells and two other infants required a bolus of 10 mg/kg caffeine to treat
apnea and desaturation. While ventilatory support was used, none of the infants required
endotracheal intubation and mechanical ventilation. The blood gas did not show any significant
increases in carbon dioxide levels.
This study is based on a single analgesic protocol using the opioid fentanyl. A calculation
of the power of the study could not be performed due to the nature of the study, which reviewed
cases treated with a new anesthetic technique with comparisons made only among relevant
variables. The sample size is small, with 9 male and 4 female neonates. Exclusion criteria were
not discussed. Chronic lung disease was present in 11 infants, although only 1 required nasal
continuous positive airway pressure (nCPAP) at the time of surgery. The type of documentation
by the Neonatal Intensive Care Unit (NICU) staff is not specified as written or computer
charting.
The use of propofol with fentanyl analgesia was effective in laser surgery without adverse
effects. However, the use of propofol in children under the age of three is not recommended by
the Food and Drug Administration (FDA). It can cause severe hypotension and propofol infusion
syndrome with repeated boluses or continuous infusions greater than 24 hours. This syndrome is
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characterized by myopathy, metabolic acidosis, hyperkalemia, and acute cardiac failure. A
randomized study is needed to assess the safety of propofol in this population but may prove
difficult because of their vulnerability.
In the retrospective, longitudinal study by Jiang et al., multiple anesthesia techniques are
assessed for tolerability and efficacy during laser therapy for ROP. The article's title serves to
inform what is being investigated and the population to which it is applicable. The abstract
provides a brief overview of each section found in the study. The problem is not well defined in
the introduction, which also fails to quantify the scope of the problem by providing statistical
information. The need for the study is made evident, but research questions are not clearly
identified.
A retrospective evaluation of medical records was conducted over a specified time frame.
Group A consisted of infants receiving topical anesthesia with proxymetacaine. Group B
consisted of infants treated with intravenous fentanyl sedation. Fentanyl was given at 2 ug/kg via
a pump over 20 min prior to surgery and continuously at 2 ug/kg/hr during treatment. Group C
comprised infants receiving general anesthesia with halothane inhalation and neuromuscular
blockade. Intubation and mechanical ventilation were employed with groups B and C. The
position of the infant's head was maintained with an assistant. NICU nurses or assistants
provided stimulation to eliminate bradycardic (heart rate of 90 beats per minute or less) or apneic
(cessation of respiratory activity for 20 seconds or more) episodes.
Group A contained 31 subjects, Group B had 47 subjects, and Group C contained 19
subjects. The study population was said to be heterogeneous, but inclusion and exclusion criteria
were not provided. Topical tropicamide eye drops were administered three times in 20-minute
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intervals in addition to proxymetacaine 0.5% given 5 minutes before and immediately before the
procedure. The number of laser burns to each eye varied for each subject.
On average, ophthalmologists needed 12-16 minutes more to complete the procedure
compared to groups B and C. Excessive head movement was observed in the infants in group A.
An accurate baseline stability was obtained and the greatest instability was observed in group A.
Four infants in this group suffered life-threatening respiratory distress or hypoxia requiring
resuscitation. No difference was observed postoperatively in groups B and C. Fentanyl sedation
was well tolerated and a safe analgesia modality with no occurrence of life-threatening events.
Fentanyl is highly efficient, sustainable, displays satisfactory neonatal pain agitation and
sedation scale (N-PASS) scores, and maintains a more stable cardiorespiratory status during and
after laser treatment for ROP.
Unlike the study by Sethi et al., which utilized a PIPP-R score to evaluate pain, this study
used the N-PASS every 20 minutes and cardiorespiratory index (CRI) by Haigh to assess the
tolerance of fentanyl sedation. N-PASS scores include crying/irritability, behavioral state, facial
expression, extremities tone, and vital signs. Vital signs were only recorded in the NICU
monitoring chart every half hour during laser treatment and 2 hours following the procedure.
Additionally, a radiant warmer was used, the neonate was swaddled, and a pacifier was offered.
Only one other study, the last randomized trial discussed, implemented one of these
interventions.
The N-PASS score was only used for the fentanyl group, making it difficult to determine
differences in pain control between the groups. The retrospective nature of the study did not
allow a definitive determination of causality of postoperative cardiorespiratory instability.
Another shortcoming of this study is unresolved questions, including the optimal fentanyl dose to

19
be used that avoids possible oversedation. These questions can be addressed in a prospective
study.
The research by Örge et al. is based on an observational study. A time frame and a
description of each section of the study is found in the abstract. The purpose of the article is
identified to compare the complication rates of two opioids, fentanyl and morphine, for laser
therapy for ROP. Evaluating the complication rates serves as the premise that fentanyl is a safe
analgesic agent for this surgery.
The medical records of preterm infants undergoing laser photocoagulation for ROP by a
single surgeon were reviewed. Exclusion criteria were patients who received only general
anesthesia or sedation. Of the 40 medical records and 53 treatments reviewed, 42 met the
inclusion criteria. A single treatment was randomly selected for infants who received multiple
procedures. The study included 39 patients: 17 in the morphine group and 18 in the fentanyl
group. Baseline ventilation status was obtained before surgery. The rate of complications that
were documented includes apneic episodes, bradycardic episodes, temperature instability,
desaturations, and changes in ventilation status during the surgery. A nurse and neonatology
physician observed and recorded the sedation flow sheet. A completed NICU standardized
sedation flow sheet documenting vital signs in 5-minute intervals and any complications were
used just as in previous studies.
The rate of change in ventilation status following administration of anesthesia and during
ROP surgery was the primary outcome. Temperature instability (measured outside of the normal
range of 36.5 ºC- 37.4 ºC), apnea (a 20-second interval without respiratory effort), bradycardia
(heart rate less than 80 beats per minute), and desaturation events (oxygen saturation less than
85%) were secondary outcomes. Fentanyl was administered at 1 mcg/kg, diluted to 2 ug/ml, and
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infused over 20 minutes. The occurrence of apneic events, temperature instability, bradycardia,
and worsening of ventilatory status were increased in the morphine group compared to the
fentanyl group. The incidence of desaturation events was higher in the fentanyl group but did not
alter ventilatory status.
Less respiratory compromise and fewer adverse events were observed with fentanyl than
morphine. This leads to the conclusion that fentanyl may be a safer anesthetic agent for ROP
laser surgery. However, the small sample size limits the statistical significance of comparing
these two opioids and establishes the need for a prospective, randomized study to determine a
true association that can inform practice guidelines. The study is further limited by its
retrospective nature and low complication rates. The anxiolytic, midazolam, was not used in any
other studies, and it is unclear whether its use in both groups on a case-by-case basis had any
effect on the complication rates.
The open-label randomized trial by Madathil et al. was based on current research and has
an experimental design that ranks as Level I evidence, answering the question of the efficacy of
two interventions. The title reflects the interventions to be investigated and the population in
which it is studied. An overview of each section of the study is listed in the abstract. The scope
of the problem is not discussed except in the setting of a tertiary care institution where the study
was conducted. Although statistical information is not provided, the problem and its implications
are well defined along with the proposed interventions. The introduction clearly states the study's
intent to find an optimum regimen useful for providing sedation and analgesia during laser
photocoagulation.
This study contained two intervention arms. A control arm could not be included in the
study design because it would be considered unethical to withhold analgesia for this procedure.
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Inclusion and exclusion criteria were very specific. Allocation of the study participants into the
two groups was performed by an independent investigator who generated random sequences that
were serially numbered and concealed. Outcome assessors were blinded to the groups, but
blinding could not be done because of the nature of the interventions.
One group received an intravenous fentanyl bolus followed by an infusion and the other
group received intermittent ketamine boluses. In the first group, an intravenous fentanyl bolus of
2 ug/kg was given over 5 minutes, 15 minutes prior to the procedure, and a continuous bolus was
initiated at 1 ug/kg/hr until completion of the procedure. Inadequate responses evidenced by
restlessness, increased crying from baseline, facial expression suggestive of pain, and a sustained
increase in heart rate greater than 24 beats from baseline allowed titration by 0.5 ug/kg/hr every
15 minutes to a maximum of 3 ug/kg/hr. In the other group, an intravenous ketamine bolus dose
of 0.5 mg/kg was administered 1 minute prior to the procedure and the same dose given
intermittently every 10 minutes to a maximum of 2 mg/kg (four doses) if inadequate responses
were observed. Both groups received topical anesthesia with 0.5% ophthalmic paracaine drops
every 20 minutes during the procedure and were swaddled. If the infant developed hemodynamic
instability, bradycardia, or apnea (no respiratory effort for more than 20 seconds or of lesser
duration if accompanied by bradycardia or desaturation less than 85%), subsequent doses of
ketamine and fentanyl infusion were not administered.
A power analysis was conducted to determine the sample size needed for the randomized
trial. Initially, of the infants screened during a specified period, 97 infants were enrolled. There
were 51 infants in the fentanyl group and 46 in the ketamine group. The regimen was
subsequently revised to an increased fentanyl bolus of 2 ug/kg followed by a 2 ug/kg/hr infusion
to a maximum of 5 ug/kg/hr. Ketamine was increased to a bolus dose of 1 mg/kg followed by
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intermittent doses of 0.5 mg/kg to a maximum of 4 mg/kg. An additional 27 infants were
enrolled (14 in the ketamine group and 13 in the fentanyl group).
Adequate anesthesia was measured every 15 min by PIPP-R scores of less than 7 and the
proportion of time, less than 5%, that the infant cried during the procedure (calculated by using
the duration of time the infant cried divided by the total procedure time). An independent
assessor analyzed the continuous voice recording of the infant to calculate this proportion.
Blinded to the group allocations, two independent assessors analyzed the video recordings. A
baseline video recording was done then completed every 15 minutes until the end of the
procedure. In comparison to the study by Sethi et al., PIPP-R scores were taken every 10 minutes
and an average was obtained.
A score of 7-12 was indicative of mild to moderate pain and a score greater than 12
indicated severe pain. Secondary outcomes include apnea, upgrade of respiratory support due to
a change in mean cardiorespiratory stability score (devised by Haigh), vasoactive support or fluid
boluses for hemodynamic instability, urinary retention for 12 hours that required catheterization,
feeding intolerance (recurrent vomiting, abdominal tenderness, increase in abdominal girth by
more than 2 cm before feeding, gastric residual of more than 50% of feed volume), hemorrhagic
aspirates, bloody stools, and NICU admission for 24 hours or greater.
A greater proportion of analgesia was observed in the fentanyl group compared with the
ketamine group, but both groups did not achieve adequate anesthesia. The need for supplemental
oxygen during the procedure compared to post-procedure was increased for both fentanyl and
ketamine. Apnea during the procedure was also increased in comparison to post-procedure for
both regimens. The regimens were well tolerated and there was no difference in side effects postprocedure. Adequate analgesia was only observed in the revised regimens.
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When considering limitations to the study, the sample size was sufficient but lacked
complete birth and caregiving data due to the enrollment of referred infants. A majority of
enrolled infants weighed 1500g or greater, making the applicability of study results to very low
birth weight infants difficult. Although baseline characteristics were similar in both groups, the
fentanyl group had a slight male preponderance. In the study, a robust methodology was
employed, high-quality interventions were implemented, and proposed outcome measures that
are clinically relevant were achieved, and results are displayed in several tables and flow
diagrams.
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Table 3. Report of Selected Studies
Author(s)
Purpose
Methodology
/ Research
Design
To compare the
Open Label
Sethi et al.
efficacy of low
Randomized
(2019)
dose fentanyl
Clinical Trial
infusion and 24% Level 1
oral sucrose in
providing optimal
pain relief during
laser surgery for
ROP

Piersigilli et
al. (2019)

To introduce a
protocol for laser
treatment of ROP
to avoid
intubation and
minimize side
effects of
anesthesia and
ventilation

Retrospective
review,
Level III

Intervention(s)/
Measures

Sampling/Setting

Primary Results

Low dose fentanyl
infusion 1 mcg/kg/hr
versus single oral
dose of 24% sucrose;
patients were
spontaneously
breathing

Sufficient sample
size, preterm
infants enrolled (n
= 58), fentanyl
group (n = 29), oral
24% sucrose group
(n = 29)

Median proportion of time
spent crying and average
PIPP-R score during the
procedure was significantly
less in the fentanyl group
compared with the oral
24% sucrose group

Study conducted in
a level 3 NICU in
North India
A retrospective
Sample size among Laser surgery was
review was performed retrospective results completed without
on preterm infants
was small (n = 13)
intubation, 4/13 infants
affected by ROP
required minimal
stage III- IV who
Study conducted in respiratory support, heart
received 5% propofol the Department of
rate post procedure was
at 2-4 mg/kg, then
Neonatology of the elevated but within normal
4mg/kg/hr
Bambino Gesu
range, no bradycardia or
continuously during
Children’s Hospital hypotension
the procedure to a
in Rome, Italy
max dose of 6
mg/kg/hr and a
fentanyl bolus of 1
ug/kg for the laser
treatment of ROP;
LMA was placed and
patients were
ventilated with a

Relevant Conclusions

Low dose fentanyl
(1mcg/kg/hr) infusion
found to be safe and
effective in reducing
pain

The study concluded
that a good level of
anesthesia and
analgesia was achieved
and maintained during
laser photocoagulation
which prevented
intubation and
mechanical ventilation
during and after the
procedure
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flow-inflating
resuscitation bag

Jiang et al.
(2017)

To assess the
efficacy and
tolerability of
anesthesia
techniques for
laser therapy in
premature infants

Retrospective
review,
Level III

A retrospective
review was performed
on preterm infants
who received laser
photocoagulation
surgery for ROP
Three groups: A
received topical
anesthesia with
proxymetacaine, B
received intravenous
fentanyl sedation at a
dose of 2 ug/kg via a
pump over 20 min
prior to surgery and
continuously at 2
ug/kg/hr during the
procedure, C received
general anesthesia
with halothane
inhalation and
neuromuscular
blockade; group B
and C were intubated
and mechanically
ventilated

Sample size among
retrospective results
was large (n = 97),
topical anesthesia
(n = 31), fentanyl (n
= 47), general
anesthesia (n = 19)
Study conducted in
the Department of
Neonatology of the
Guangdong Women
and Children’s
Hospital in
Guangzhou, China
between July 2013December 2014

N-PASS score used to
evaluate tolerability of
laser treatment was 1.8 for
fentanyl indicating a
satisfactory level of pain

Findings concluded
that fentanyl is highly
efficient and maintains
a more stable
cardiorespiratory
condition during and
after laser therapy
An optimal fentanyl
dose is needed to avoid
possible oversedation
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Radiant warmer was
used, neonate was
swaddled and a
pacifier offered
Örge et al.
(2013)

To compare the
Retrospective
complication rates review,
of morphine and
Level III
fentanyl in
preterm infants
undergoing laser
therapy for ROP

A retrospective
review was performed
on preterm infants
who received laser
treatment for ROP

Madathil et
al., (2021)

To investigate if
intravenous
ketamine or
intravenous
fentanyl can
provide adequate
anesthesia in

Intravenous fentanyl
and intravenous
ketamine were
studied

Open Label
Randomized
Clinical Trial
Level 1

Fentanyl bolus of 2
ug/kg given over 5

Sample size among
retrospective results
was small (n = 35),
morphine (n = 17),
fentanyl (n = 18)

Worsening of ventilation
status: 5/17 (29%) for
morphine group and 1/18
(6%) for fentanyl group;
Temperature instability:
1/17 (6%) for morphine
Study conducted at group and none in the
the NICU of
fentanyl group; Incidence
Rainbow Babies
of apneic events: 6/17
and Children’s
(35%) for the morphine
Hospital, Case
group and 2/18 (11%) in
Western Reserve
the fentanyl group;
University from
Incidence of bradycardic
June 2007 to
events: 7/17 (41%) for the
September 2010
morphine group and 5/18
(28%) in the fentanyl
group; Incidence of
desaturation events: 9/17
(53%) in the morphine
group and 12/18 (67%) in
the fentanyl group
Sufficient sample
Proportion of infants with
size, infants
adequate anesthesia was
enrolled (n = 97),
low, 16.3% for fentanyl
fentanyl group (n = group and 4.5% for
51), ketamine group ketamine in the initial
(n = 46) with the
regimen
initial regimen

Fentanyl may be a safer
form of anesthesia for
ROP laser surgery as it
is associated with fewer
adverse events and less
respiratory compromise

Fentanyl and ketamine
provided adequate
anesthesia in a minority
of preterm infants,
more studies are
needed to determine
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preterm neonates
undergoing laser
photocoagulation
for ROP

minutes, 15 minutes
prior to the procedure,
a continuous bolus
was initiated at 1
ug/kg/hr until
completion of the
procedure;
intravenous ketamine
bolus dose of 0.5
mg/kg 1 minute prior
to the procedure and
intermittently every
10 minutes to a
maximum of 2 mg/kg
(four doses)
Both groups received
topical anesthesia
with 0.5% ophthalmic
paracaine drops every
20 minutes during the
procedure, patients
were swaddled
Revised regimen of
fentanyl 2 ug/kg
followed by a 2
ug/kg/hr infusion to a
maximum of 5
ug/kg/hr, ketamine
bolus dose of 1 mg/kg
followed by
intermittent doses of

Study steering
committee
recommended
higher doses and
consequently,
additional infants
were enrolled (n =
27), fentanyl group
(n = 13), ketamine
(n = 14)
Study conducted in
a day care facility
of a tertiary care
hospital in North
India between April
16, 2018 and May
5, 2019

Adequate anesthesia was
higher with the revised
regimen, 23.1% for
fentanyl group and 7.1%
for ketamine
PIPP-R scores and
percentage cry duration
were better

adequate procedural
analgesia
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0.5 mg/kg to a
maximum of 4 mg/kg
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Discussion
Anesthetic support varies greatly and there are no specific guidelines for which type of
anesthesia is preferable.6 This is likely due to the limited literature that is available for anesthetic
management for ROP screening and therapy.7 The open label randomized trial by Sethi et al.
compared oral sucrose and a low dose fentanyl infusion. It is the first randomized controlled
study with an adequate sample size to assess the effect of sucrose and fentanyl in the first 24
hours post procedure. It minimized bias by using independent clinicians to assess primary and
secondary outcomes. Oral sucrose was not effective in pain reduction as evidenced by the
percentage of time the infants spent crying. Intravenous fentanyl was associated with a decreased
pain response and observed to be a safe analgesic post procedure.4
To ensure that infants receive optimal intervention, safe and effective anesthesia
manipulation is necessary for ROP procedures. Fentanyl sedation and general anesthesia were
well tolerated without life-threatening events. Yet, the use of general anesthesia can lead to
back-and-forth transfer of an infant to a higher level hospital.6 Opioid analgesia avoids the risks
associated with general anesthesia such as complications with postoperative extubation.8
However, opioid dosing must be optimized to prevent potential oversedation, accompanying
postoperative pain, and prolonged ventilation.6
While ketamine is a potent analgesic that does not require intubation, thereby preserving
airway patency and respiratory function, its use is questionable due to significant movement and
concerns regarding neurotoxicity.9 Intravenous fentanyl is more potent, has a rapid onset of
action, and penetrates the central nervous system.8 Surgery was successful with fentanyl,
intubation was avoided, and no serious adverse events were encountered.10 These evidencebased research studies lay the groundwork for the quality improvement (QI) project. An
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educational module will be created based on the findings in the research studies. Using a
questionnaire, the knowledge of anesthesia providers will be assessed before and after teaching
an effective analgesic protocol for ROP procedures.
Purpose/PICO Clinical Questions/Objectives
PICO Question or Purpose
Population (P): Anesthesia providers
Intervention (I): Educational intervention
Comparison (C): None
Outcomes (O): Improved knowledge of analgesia in procedures for retinopathy of prematurity
There are several objectives for the literature review conducted on the topic of interest. Current
research is investigated to find and compare analgesic modalities used for treating pain in infants
undergoing ROP procedures. The protocols are carefully reviewed to determine an optimal
anesthetic agent that minimizes adverse events. The most effective pain management protocol is
identified by evaluating the research studies that utilize evidence-based practice. This anesthesia
protocol, which has demonstrated improved patient outcomes, will lay the foundation for
improving knowledge in anesthesia providers who provide anesthesia care for ROP.
Primary DNP Project Goal
Retinopathy of prematurity (ROP), initially named retrolental fibroplasia, was recognized
in 1942. It is a proliferative disorder that can occur in the immature retinal vasculature of
premature infants.2 The pathogenesis of ROP is not well understood but vascular endothelial
growth factor (VEGF) is known to play an essential role in the development of ROP. Its
dysregulation causes abnormalities in vasculogenesis and neovascularization. Laser therapy
prevents blindness by suppressing overproduction of VEGF in the retina and helps induce the
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regression of new vessels via ablation of peripheral retina ischemic areas.3 ROP, if left
untreated, predisposes infants to develop myopia, strabismus, vitreoretinal fibrosis, vitreous
hemorrhage, secondary angle closure glaucoma, retinal detachment, and ultimately complete
vision loss. As survival rates continue to improve since the 1980s due to advances in neonatal
care, increased immaturity leads to a higher likelihood of developing ROP. The re-emergence of
ROP is a significant cause of blindness in the developed world. Early screening and treatment
are crucial in the prevention and management of this disease.2

Therapy modalities are dependent on the stage and severity of ROP. They include
cryotherapy, laser photocoagulation, and vitreoretinal surgery for severe cases. Laser therapy is
the treatment of choice for less severe ROP. This is because it can target tiny vessels with more
precision, burning abnormal ones while leaving the surrounding tissue unaffected. These tissues
are important for subsequent vascularization. As the laser makes more refined burns on the
retina, the accuracy of the treatment of the vessels is improved. While this may cause pain, the
use of the eyelid speculum is thought to be the primary source of pain for this population and
causes infants to be unstable. Controlling pain in the preterm neonate is problematic due to their
vulnerability which may limit the use of pharmacological analgesic interventions.2 Uncontrolled
pain can lead to hemodynamic instability, apnea, increased intracranial pressures, altered pain
processing, impaired visual perceptual ability, and attention deficit disorder.4

Anesthetic care treatments include topical analgesia with or without oral sucrose, general
anesthesia (GA) with intubation, and the most popular choice of intravenous sedation (IVS) and
analgesia with elective ventilation.2 GA and IVS can cause respiratory depression in the neonate
requiring intubation and ventilation. Chronic lung disease is a systemic consequence of
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prematurity and predisposes infants to respiratory compromise. Reintubation can result in acute
trauma to the mouth, nose, larynx, pharynx, cause bradycardia, hypoxia, and lung injury from
positive pressure ventilation. Anesthesia protocols are needed to determine analgesia that is
efficacious for procedural pain during treatment for ROP. These protocols will guide anesthesia
providers in utilizing optimal pharmacological agents for pain relief in this vulnerable
population.5 The focus of this project is to improve knowledge base among providers regarding
pain management in infants who need therapy for ROP.

Goals and Outcomes
The SMART acronym describes the framework utilized to guide the development of the
goal objectives. According to SMART, objectives should be specific, measurable, achievable,
realistic, and time-phased.12
Specific
Anesthesia providers will increase their knowledge of a standardized evidence-based
protocol for the management of anesthesia care for patients who undergo procedures for ROP.
Measurable
The effectiveness of the ROP protocol was evaluated following analysis of a
questionnaire provided to participants before and after an educational intervention. Outcomes
were measured by evaluating the current knowledge of pain management for ROP procedures
and comparing this to knowledge acquired post-intervention which can be applied in clinical
practice. The Qualtrics online survey system software was used to create surveys and conduct
data analysis.
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Achievable
Anesthesia providers including anesthesiologists, certified registered nurse anesthetists
(CRNAs), and anesthesiologist assistants (AA) were educated in appropriate anesthetic and
analgesic agents for pain management in infants requiring intervention for ROP.
Realistic
Anesthesia providers were presented with an education module for the management of
anesthesia care. The module included appropriate anesthetic and analgesic agents for procedures
for ROP.
Timely
The educational module for anesthesia care protocols for patients undergoing intervention
for ROP was completed and available to anesthesia providers within a period of 1 month. The
outcome of this initiative was for anesthesia providers to have access to anesthetic protocols to
minimize pain and provide optimal care for ROP procedures.
Definition of Terms
Retinopathy of prematurity – a vasoproliferative disorder of the retinal vessels which
primarily affects premature infants and can lead to blindness3
Analgesia – is the relief from pain as achieved from the use of an analgesic agent4
Fentanyl – opioid analgesic agent used in the management of pain4
Sucrose – oral sweetener solution used in the management of pain4
Laser Photocoagulation – a form of corrective laser surgery for the eyes1
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Methodology
Settings and Participants
This project took place in hospital, which has a neonatal intensive care unit that may
request anesthesia for infants affected by retinopathy of prematurity. There are several
anesthesia providers including anesthesiologists, certified registered nurse anesthetists, and
anesthesia assistants. Some are staff and may work full time, part time, or per diem status while
others may work as contractors with a medical staffing agency. The hospital is located in
Hollywood, FL with providers of diverse educational backgrounds.
Description of Approach and Project Procedures
The DNP project intervention was initiated by inviting the anesthesia providers of the
designated hospital to participate in the study. A pretest/posttest design was used to assess
knowledge of analgesics for procedural pain in infants requiring screening and therapy for ROP.
Before the educational intervention, data was collected on educational level, years in practice,
and frequency of work interaction with the population being studied. The educational
intervention had a duration of approximately 45 minutes. Participants were asked to complete
the posttest following completion of the intervention.
Protection of Human Subjects
The Institutional Review Board (IRB) makes the determination of any risks to potential
participants. If any risk is noted, informed consent was obtained prior to the initiation of the
project via Qualtrics. Participants may withdraw from the project at any time. The benefit of
participation to the anesthesia providers is the improved knowledge of an anesthetic protocol
that minimizes pain in the infant undergoing procedures for ROP.
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Data Collection
Education was the primary demographic data to be collected. Years of practice
experience and educational data were collected from the participants as educational level can
vary among anesthesia providers. Anesthesiologists attend medical school, and CRNAs are
registered nurses who attend anesthesia programs, which depending on the timeframe they
attended school, may possess a certificate, master’s, or doctoral degree. These providers may
practice autonomously depending on what state they practice. However, in the state of Florida,
CRNAs work under the supervision of the anesthesiologist. An AA can only work under direct
supervision of the anesthesiologist. These various anesthesia providers completed pre- and
posttests of the educational intervention, and the data collected was analyzed and reported.
Data Management and Analysis Plan
Data collected were stored electronically. Only the primary investigator had access to the
stored data. Direct identifiers were not collected. Questionnaires obtained via Qualtrics surveys
were used to compare knowledge pre and post intervention.
RESULTS OF QUALITY IMPROVEMENT
Pretest and Posttest Sample
After accessing the Qualtrics Online Survey System, the preintervention survey contained
5 participants. Of the 5 participants, 4 answered the demographic questions. One participant
could not complete the study due to errors with question display. An evaluation of the posttest
survey showed that 2 participants did not complete the survey. Thus, the preintervention sample
contained 4 individuals, and the posttest sample contained 3 individuals.
Participants varied in age, gender, race, and the number of years in anesthesia practice.
All the preintervention participants were female. Age of the participants ranged from 38 to 50
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years old (n = 4) with a majority of the participants being over the age of 47. The participants’
race varied with African Americans serving as the largest group of participants (n = 2). There
was 1 Hispanic and 1 Caucasian participant. CRNAs were the only group who responded (n =
4) with most CRNAs having greater than 10 years of experience (n = 3) and 1 CRNA with 1-2
years of experience (n = 1). Table 3 provides the complete demographic breakdown of the
preintervention sample.
Three (n = 3) of the original four participants participated in the educational module and
completed the posttest survey. All of the participants were CRNAs (n = 3; 100%) and were
females (n = 3; 100%). Of these individuals, two were between the age of 46-55 (n =2; 66.6%)
and one was between the age of 36-45 (n = 1; 33.3%). The data represented a range of
ethnicities including Hispanic (n = 1; 33.3%), Caucasian (n = 1; 33.3%), and Black or African
American (n = 1; 33.3%). Additionally, the data represented individuals of various years of
anesthesia practice including 1-2 years (n = 1; 33.3%) and >10 years (n = 2; 66.6%).
Demographics of the postintervention participants is displayed in Table 3.
Table 4. Demographics
Demographic item

Pre-Intervention
Demographics
N=4
Count; Percent

PostIntervention
Demographics
N=3
Count; Percent

Male

0; 0

0; 0

Female

4; 100%

3; 100%

25-35

0; 0

0; 0

36-45

1; 25%

1; 33.3%

Gender

Age (years)
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46-55

3; 75%

2; 66.6%

Hispanic

1; 25%

1; 33.3%

Caucasian

1; 25%

1; 33.3%

Black or African
American

2; 50%

1; 33.3%

Asian

0; 0

0; 0

Other

0; 0

0; 0

Anesthesiologist
(MD)

0; 0

0; 0

Certified Registered
Nurse Anesthetist
(CRNA)

4; 100%

3; 100%

0; 0

0; 0

Masters

1; 25%

1, 25%

Doctorate

3; 75%

2; 75%

Other

0;0

0;0

1-2

1; 25%

1; 33.3%

2-5

0;0

0;0

5-10

0;0

0;0

>10

3; 75%

2; 66.6%

Race

Position/ Title

Anesthesiologist
Assistant (AA)
Level of Education

Anesthesia
experience (years)
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Pretest Knowledge
The purpose of the pretest was to assess current knowledge about analgesia for ROP.
Four individuals took the pretest and three completed the posttest. Table 5 displays the scores
and differences for both components. The pretest showed that the participants were
knowledgeable on the opioid observed to be a safe analgesic (n = 4, 100%). However, it showed
a lack of knowledge in an effective dose of fentanyl for sedation following a bolus dose (n= 2,
50%), the primary source of procedural pain (n = 2, 50%), and anesthesia modalities in
procedures for ROP (n = 2, 50%).
Participants were asked to rate their likeliness to use fentanyl as an analgesic to manage
pain in infants undergoing procedures for ROP. In the preintervention survey, the participants
answered as follows: extremely unlikely (n = 2, 50%), somewhat unlikely (n = 1, 25%), and
extremely likely (n = 1, 25%). When asked the likeliness to recommend fentanyl sedation as an
opioid of choice for ROP treatment, participants in the postintervention survey responded as
follows: neither likely nor unlikely (n = 3,75%) and extremely unlikely (n = 1, 25%). This data
in shown in Table 6.
Table 5. Difference in Pre- and Posttest Knowledge
Questions
1. The percentage
of premature infants
weighing less than
1500g that develop
ROP
2. Irreversible
visual impairment
due to ROP
worldwide may be
as high as
3. Risk of
developing ROP is
higher in
4. Untreated ROP
may lead to

Pre-test

Post-test

Difference

50%

100%

+50%

25%

33.3%

+8.3%

50%

66.6%

+16.6%

50%

66.6%

+16.6%
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5. Consequences of
pain in infants
include all of the
following except
6. Long term
consequences of
untreated pain in
infants include
7. The primary
source of
procedural pain is
related to
8. Anesthesia
modalities in
procedures for ROP
include
9. Sucrose is
effective for pain
management in
procedures for ROP
10. What
percentage of
infants are
intubated to prevent
the adverse
respiratory effects
associated with
ROP procedures
11. The opioid
observed to be a
safe analgesic with
a rapid onset,
penetrates the
central nervous
system and
associated with a
decreased pain
response is
12. Which is true
regarding a low
dose fentanyl
infusion for
sedation
13. What is an
effective dose of
fentanyl for
sedation following a
bolus dose

50%

66.6%

+16.6%

50%

66.6%

+16.6%

50%

100%

+50%

50%

100%

+50%

50%

33.3%

-16.7%

25%

100%

+75%

100%

100%

0

75%

66.6%

-8.4%

50%

100%

+50%
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Table 6. Difference in Pre- and Posttest Perspective of Fentanyl as an Effective Analgesic For
ROP
14. How likely are you to use this analgesic modality to manage pain in infants undergoing
procedures for ROP?
Neither likely nor
unlikely
Somewhat likely
Extremely likely
Somewhat unlikely
Extremely unlikely

Pretest

Posttest

Difference

0

33.3%

+33.3%%

0
25%
25%
50%

33.3%
33.3%
0
0

+33.3%
+8.3%
-25%
-50%

15. How likely are you to recommend fentanyl sedation as an opioid of choice for ROP
treatment?
Neither likely nor
unlikely
Somewhat likely
Extremely likely
Somewhat unlikely
Extremely unlikely

Pretest
75%

Posttest
33.3%

Difference
-41.7%

0
0
0
25%

33.3%
33.3%
0
0

+33.3%
+33.3%
0
-25%

Posttest Knowledge
Posttest scores are displayed in Table 5. After viewing the educational module, most
areas showed improvement. There were a few that showed a decrease or stagnancy in
knowledge. An increase in knowledge of 50% was observed in the question regarding the
population affected by ROP. An increase in knowledge of 50% was also observed in the
question regarding pain related to the treatment of ROP and an effective dose of fentanyl for
sedation following a bolus dose. The questions regarding risks factors for developing ROP and
consequences of ROP showed improvement of +16.6%. There was no change in the question
regarding the opioid observed to be a safe analgesic with a rapid onset as both the pretest and
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posttest showed a 100% pass rate. Thus, participants answered the question correctly before and
after the educational module. An unfavorable change was observed in two questions of the
survey. Sucrose as an effective intervention for pain management in procedures for ROP
showed a decline by 16.7% and a low dose fentanyl infusion for sedation showed a decline by
8.4%.
The change in perspective of fentanyl as an effective analgesic for ROP is depicted in
Table 6. There was a 33.3% change in the participants who were somewhat likely or neither
likely nor unlikely to use fentanyl to manage pain in infants undergoing procedures for ROP.
Additionally, there was an 8.3% change in those who were extremely likely to use the analgesic
modality. Thus, a positive difference was demonstrated for all these responses. Similarly, the
postintervention results of the likeliness to recommend fentanyl sedation as an opioid of choice
for ROP treatment showed an improvement in perspectives. Participants were 33.3% extremely
likely and somewhat likely to recommend fentanyl.
Summary of Data
Overall, a small change in knowledge occurred as reflected in Table 5. The average score
of the pretest was 67.5 and the average score of the posttest was 79.9 with an overall average
improvement of 8.46. There was a 50% improvement in knowledge about the population
affected by ROP, the primary source of pain related to ROP procedures, treatment modalities for
ROP procedures, and an effective dose of fentanyl for sedation. The pretest and posttest showed
a minor improvement in 6 questions and no change in knowledge for one of the questions. It
should be noted that the latter question was answered correctly in the pretest and posttest. Lower
posttest scores were observed in 2 areas including sucrose utilization for ROP procedures and a
low dose fentanyl infusion, indicating a decrease in knowledge. A change in perspective towards
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utilization of fentanyl as an analgesic was observed. Participants are extremely likely or
somewhat likely to use and recommend fentanyl for sedation for ROP.
Limitations
A significant limitation of this survey was the sample size. While the survey was
distributed via email to 37 people, only 3 individuals completed the pre-intervention and postintervention surveys. Reliability of the results would have been strengthened with a larger
sample size. An additional limitation of the data is that all participants were CRNAs. Thus, the
data did not represent the knowledge and attitudes of the different anesthesia providers at this
site within the healthcare system. Lastly, the delivery method of this survey may have been a
limitation. The self-paced nature of the educational module may have prevented completion of
the survey, as the participants may not have set aside adequate time to complete it. Provision of
an in-class presentation would have ensured that the participants viewed the educational module
and possibly yielded more reliable data.
Discussion of the Results with Implications to Advanced Nursing Practice
The most frequently used analgesic in infants is oral sucrose. The proposed mechanism
for its analgesic effect is believed to be the release of endogenous opioid. It is associated with a
reduction in pain behaviors in preterm and term infants for painful procedures such as
venipuncture, heel lancet prick, and intramuscular injection. It is often used in conjunction with
topical anesthesia to avoid intubation.4 This has been proven to be inadequate for surgical
treatment and increases the incidence of potentially life-threatening cardiopulmonary events.8,10
A variety of anesthesia techniques have been used for infants requiring ROP procedures.
Considerable pain during these procedures is related to mydriatic eye drops, forced eyelid
opening, insertion of blepharostat, scleral indentation, and intense illumination.13 Tenon
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anesthesia, orbital regional anesthesia such as peribulbar or retrobulbar injections, in
combination with sedation has also been used and is associated with excessive head mobility and
cardiopulmonary instability.8,10 The exclusive use of topical anesthesia is associated with severe
cardiorespiratory complications during and after ROP surgery. In addition, foveal burns may
result since topical anesthesia cannot induce ocular akinesia. More time is needed to complete
procedures under topical anesthesia and prolonged treatment is presumed to be more painful.6
A lack of evidence exists regarding analgesia protocols for ROP procedures. This is
likely due to the limited availability of studies using low-dose opioid therapy in infants receiving
laser photocoagulation for ROP. The concern lies with the risks to the infant, especially apnea
requiring intubation and mechanical ventilation.4 Nurse anesthetists are advanced practice
registered nurses who may be called to provide anesthesia that is safe and effective. Low dose
fentanyl analgesia is a safe and efficacious anesthesia modality in this population. This
anesthesia protocol may obviate the need for some hospitals to transfer cases of prematurity with
threshold ROP to tertiary hospitals to receive laser treatment and prevent ROP morbidity.6
This QI improvement project will help anesthesia providers minimizes severe and
potentially life-threatening cardiorespiratory complications during and after surgery for ROP.
The facilitation of pain management will maintain hemodynamic stability, allow surgery to be
successful, and prevent short and long-term consequences associated with prolonged pain.6
Results of the project will be provided to the NICU leadership team and the anesthesia
department. These stakeholders may choose to implement this analgesic protocol identified in
the project as a practice change that can subsequently be used to train current and new staff.
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Conclusion
Retinopathy of prematurity remains a frequent comorbidity in preterm infants. Studies
have established that infants perceive painful stimuli from ROP screening and therapy.6 Laser
treatment is most commonly used for ROP because it requires less manipulation and causes less
trauma than cryotherapy. Premature infants who received topical anesthesia for cryotherapy had
protracted and more severe cardiorespiratory complications than with sedation/analgesia or
general anesthesia.10 Complications of tenon anesthesia include rectus muscle damage, scleral
perforation, retrobulbar hemorrhage, central retinal artery occlusion, and arrest of the infant.8
Having an effective analgesic agent such as fentanyl helps to avoid extended procedures,
prevents additional pain, and subsequent short and long-term consequences associated with
prolonged pain.6
There is still no consensus on the best anesthetic approach or standard of care for those at
risk for ROP. An anesthesia protocol that provides efficient pain control to vulnerable infants is
still needed.9,10 A good level of analgesia and anesthesia can manage pain in this population
while avoiding intubation and mechanical ventilation. Fentanyl and morphine are opioids that
have been used for ROP therapy.10 Less respiratory compromise occurs with fentanyl than
morphine.8 Complication rates suggest that fentanyl is safer when evaluating overall worsening
of ventilation status temperature instability.6 While fentanyl has been used safely, an optimal
dose is recommended for future research.7 The goal remains to confer the best pain control with
minimal risk to the infant undergoing laser therapy for ROP.6 Information gathered from these
studies will guide the quality improvement project that educates anesthesia staff on an
efficacious analgesic protocol using intravenous fentanyl for ROP procedures. Using these
current evidence-based research articles, patient care and outcomes will be improved.
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APPENDIX B

CONSENT TO PARTICIPATE IN A QUALITY IMPROVEMENT PROJECT
“Improve Knowledge of Analgesia in Procedures for Retinopathy of Prematurity”

SUMMARY INFORMATION
Things you should know about this study:









Purpose: Educational module to improve knowledge in analgesia modalities in
procedures for retinopathy of prematurity.
Procedures: If you choose to participate, you will be asked to complete a pre-test,
watch a voice PowerPoint and subsequently a post test
Duration: This will take approximately 20 minutes total.
Risks: The main risk or discomfort from this research is minimal. There will be
minimal risks involved with this project, as would be expected in any type of
educational intervention, which may have included mild emotional stress or mild
physical discomfort from sitting on a chair for an extended period of time, for instance.
Benefits: The main benefit to you from this research is to increase the participant’s
knowledge of analgesia for procedural pain in infants undergoing treatment for
retinopathy of prematurity.
Alternatives: There are no known alternatives available to you other than not taking
part in this study.
Participation: Taking part in this research project is voluntary.

Please carefully read the entire document before agreeing to participate.

PURPOSE OF THE PROJECT
You are being asked to be in a quality improvement project. The goal of this project is to improve
anesthesia provider knowledge on analgesia in procedures for retinopathy of prematurity.

DURATION OF THE PROJECT
Your participation will require about 20 minutes of your time. If you decide to participate you will be 1 of
10 participants.
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PROCEDURES
If you agree to be in the project, we will ask you to do the following things:

1. Complete an online 10 question pre-test survey via Qualtrics, an Online survey product for
which the URL link is provided
2. Review the educational PowerPoint Module lasting 10 minutes via Qualtrics, an Online survey
product for which the URL link is provided.
3. Complete the online 10 question post-test survey via Qualtrics, an Online survey product for
which the URL link is provided.

RISKS AND/OR DISCOMFORTS
The main risk or discomfort from this research is minimal. There will be minimal risks involved
with this project, as would be expected in any type of educational intervention, which may have
included mild emotional stress or mild physical discomfort from sitting on a chair for an
extended period of time, for instance.
BENEFITS
The following benefits may be associated with your participation in this project: An increased
understanding of analgesia for infants undergoing procedures for retinopathy of prematurity.
The overall objective of the program is to increase the quality of healthcare delivery and improve
healthcare outcomes for our patients.

ALTERNATIVES
There are no known alternatives available to you other than not taking part in this project. However, if
you would like to receive the educational material given to the participants in this project, it will be
provided to you at no cost.

CONFIDENTIALITY
The records of this project will be kept private and will be protected to the fullest extent provided by
law. If, in any sort of report, we might publish, we will not include any information that will make it
possible to identify you as a participant. Records will be stored securely, and only the project team will
have access to the records.

PARTICIPATION: Taking part in this research project is voluntary.
COMPENSATION & COSTS
There is no cost or payment to you for receiving the health education and/or for participating in this
project.

RIGHT TO DECLINE OR WITHDRAW
Your participation in this project is voluntary. You are free to participate in the project or withdraw your
consent at any time during the project. Your withdrawal or lack of participation will not affect any
benefits to which you are otherwise entitled. The investigator reserves the right to remove you without
your consent at such time that they feel it is in the best interest.

RESEARCHER CONTACT INFORMATION
If you have any questions about the purpose, procedures, or any other issues relating to this research
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project, you may contact Sandy DeJoie at 718-781-4687/ sdejo001@fiu.edu and Dr. Charles Buscemi at
305-348-4870/ cbuscemi@fiu.edu.

IRB CONTACT INFORMATION
If you would like to talk with someone about your rights pertaining to being a subject in this project or
about ethical issues with this project, you may contact the FIU Office of Research Integrity by phone
at 305-348-2494 or by email at ori@fiu.edu.

PARTICIPANT AGREEMENT
I have read the information in this consent form and agree to participate in this study. I have had
a chance to ask any questions I have about this study, and they have been answered for me. By
clicking on the “consent to participate” button below I am providing my informed consent.
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APPENDIX C

Pretest and Posttest Questionnaire:
Analgesia in procedures for retinopathy of prematurity (ROP)
INTRODUCTION
The primary aim of this QI project is to increase knowledge among anesthesia providers of
analgesia in procedures for retinopathy of prematurity in infants to improve patient outcomes in
this population.
Please answer the question below to the best of your ability. The questions are either in
multiple choice or true/false format and are meant to measure knowledge and perceptions on
analgesia in procedures for ROP.
PERSONAL INFORMATION
1. Gender: Male

Female

2. Age: ______
3. Ethnicity:
Hispanic

Caucasian

African American

Asian

Other_______________
4. Position/Title: _________________________________
5. Level of Education: Associates

Bachelors

Masters

Other ___________
6. How many years have you been an anesthesia provider?
Over 10

5-10 years

2-5 years

1-2 years
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QUESTIONNAIRE
1. The percentage of premature infants weighing less than 1500g that develop ROP:
a. 10%
b. 20%
c. 30%
d. 40%
2. Irreversible visual impairment due to ROP worldwide may be as high as
a. 20,000
b. 35,000
c. 45,000
d. 70,000
3. Risks of developing ROP is higher in:
a. Sicker infants with low birth weights
b. Infants requiring continuous positive airway pressure (CPAP)
c. Low apgar scores at five minutes
d. All of the above
4. Untreated ROP may lead to:
a. Retinal detachment
b. Development of strabismus
c. Secondary angle-closure glaucoma
d. Vitreous hemorrhage
e. All the above
5. Consequences of pain in infants include all of the following except:
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a. Apnea
b. Improved visual perceptual ability
c. Increased intracranial pressures
d. Hemodynamic instability
6. Long term consequences of untreated pain in infants include:
a. Altered pain processing
b. Impaired visual perceptual ability
c. Attention deficit disorder
d. A and C
e. All of the above
7. The primary source of procedural pain is related to
a. IV insertion
b. Eyelid speculum
c. Eye drop instillation
d. None of the above
8. Anesthesia modalities in procedures for retinopathy of prematurity include
a. General anesthesia
b. Sub-Tenon anesthesia
c. Sedation with analgesia
d. Topical analgesia
e. All of the above
9. Sucrose is effective for pain management in procedures for ROP: True or False
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10. What percentage of infants are intubated to prevent the adverse respiratory effects
associated with ROP procedures:
a. 50%
b. 70%
c. 90%
d. None of the above
11. The opioid observed to be a safe analgesic with a rapid onset, penetrates the central
nervous system and associated with a decreased pain response is:
a. Morphine
b. Ketamine
c. Dilaudid
d. Fentanyl
12. Which is true regarding a low dose fentanyl infusion for sedation
a. Is not well tolerated
b. Causes frequent life-threatening events
c. Maintains a stable cardiorespiratory status
d. Displays unsatisfactory pain scores
13. What is an effective dose of fentanyl for sedation following a bolus dose?
a. 0.5 -1 mcg/kg/hr
b. 1 -2 mcg/kg/hr
c. 3-5 mcg/kg/hr
d. 5-7 mcg/kg/hr
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14. How likely are you to use this analgesic modality to manage pain in infants
undergoing procedures for ROP?
a. Most likely
b. Somewhat likely
c. Somewhat unlikely
d. Most unlikely
15. How likely are you to recommend fentanyl sedation as an opioid of choice for ROP
treatment?
a. Most likely
b. Somewhat likely
c. Somewhat unlikely
d. Most unlikely
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APPENDIX D

Increasing Knowledge of Analgesia
in Procedures for Retinopathy of
Prematurity

Learning Goals

ROP Background
A vasoproliferative disease of developing retinal vessels

• Describe retinopathy of prematurity (ROP)

Affects approximately 30% of premature infants weighing less than 1500g

• Detail complications of ROP

Risk increases significantly in sicker infants with low birth weights

• Discuss consequences of untreated pain for ROP therapy

May lead to irreversible visual impairment or vision loss in approximately 45,600
infants annually worldwide

Sandy DeJoie, MSN, RN

• Identify anesthesia modalities
Corrective therapy is painful and requires an effective anesthesia regimen in this
vulnerable population

• Explain an effective opioid therapy that maintains hemodynamic stability

1

2

Risk factors for ROP

3

Scope and consequences of ROP

Anesthesia modalities for ROP

• Untreated ROP in premature infants can lead to retinal detachment, development of

Exposure to high oxygen concentrations

Topical analgesia with sucrose

strabismus, vitreous hemorrhage, myopia, secondary angle-closure glaucoma and vision

Infants weighing 1250g or less before 31 weeks of gestation at delivery

Sub-Tenon anesthesia

loss

Sicker infants with low birth weights

Sedation with analgesia

• Laser treatment is the most effective therapy but is painful with eye speculum use as the

Infants requiring continuous positive airway pressure (CPAP)

General anesthesia

primary source of pain

Low apgar scores at five minutes

• Pain contributes to instability including increased hemodynamic instability, apnea,
increased intracranial pressures, and altered pain processing
• Long term consequences include altered pain processing, impaired visual perceptual
ability, and attention deficit disorder

4

5

Anesthesia management for ROP

6

Summary
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